Pharmacological investigation of protective effects of Nigella sativa oil in experimental diabetic neuropathy in rats

Indian Journal of Pharmaceutical Education and Research

Volumn 43, Issue 2, 2009, Pages 166-176

  Ansari, Mohammad Abid ^a   Ahmad, Shibli Jameel ^a   Khanum, Razia ^a   Akhtar, Mohammad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antioxidant enzymes; Diabetic neuropathy; Nigella sativa oil

Indexed keywords

AMITRIPTYLINE; CATALASE; GLUCOSE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; NIGELLA SATIVA EXTRACT; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK CUMIN; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GRIP STRENGTH; HISTOPATHOLOGY; HYPERALGESIA; HYPOGLYCEMIA; MEDICINAL PLANT; NOCICEPTION; NONHUMAN; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 70350163797     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bhadada SK, Sahay RK, Jyotsna VP, Agrawal JK. Diabetic Neuropathy: Current Concepts. Journal of Indian Academy of Clinical Medicine 2001; 2(4): 305-308
2. Hall GC, Carroll D, Parry D, McQuay JH. Epidemiology and treatment of neuropathic pain, The UK primary care perspective. Pain 2006 ; 122 : 156-162
3. Al-Shabanah OA, Badary OA, Naagi MN, Al-Gharably NM, Al- Rikabi AC, Al-Bekairi AM. Thymoquinone protects against doxorubicininduced cardiotoxicity without compromising its antitumor activity. Journal of Experimental and Clinical Cancer Research 1998; 17: 193-198
4. Al-Majed AA, Daba MH, Asiri Y.A, Al-Shabanah OA, Mostafa AA, El-Kashef HA. Thymoquinoneinduced relaxation of guinea pig isolated trachea. Research Communications in Molecular Pathology and Pharmacology 2001; 110(5-6):333-345 (Pubitemid 36896942)
5. Badary OA, Abdel-Naim AB, Abdel-Wahab MH, Hamada FM. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 2000; 143(3): 219-226 (Pubitemid 30089521)
6. Aboul-Ela EI. Cytogenetic studies on Nigella sativa seeds extract and thymoquinone on mouse cells infected with schistosomiasis using karyotyping. Mutation Research 2002; 516 (1-2): 11-17
7. Badary OA, Gamal El-Din, AM. Inhibitory effects of thymoquinone against 20-methycholanthreneinduced fibrosarcoma tumorigenesis. Cancer Detection and Prevention 2001;25(4): 362-368
8. Tahir KE, Ashour MM, Al-Harbi MM. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. General Pharmacology 1993; 24: 1123-1131 (Pubitemid 23283080)
9. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M.. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 2000; 55(3): 379-382
10. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Annals of Allergy 1993;70: 237-242 (Pubitemid 23085939)
11. El-Dakhakhny M, Barakat M, El-Halim MA, Aly SM. Effects of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. J Ethnopharmacol 2000;72(1-2): 299-304. (Pubitemid 30680068)
12. Mahmoud MR., El-Abhar HS, Saleh S. The effect of Nigella sativa oil against the liver damage induced by Shistosoma mansoni infection in mice. Journal of Ethnopharmacology 2002; 79: 1-11. (Pubitemid 34017233)
13. El-Dakhakhny M, Mady N, Lambert N, Ammon HP.The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatric actions. Planta Med 2002; 68:465-466 (Pubitemid 34606696)
14. Omar A, Rodrigues F, Val'eria Paula Sassoli Fazan. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats. Journal of Neuroscience Methods 2006; 151: 131-138
15. Ali A, Pillai KK, Vohora D, Ahmad FJ. Evidence of the antiepileptic potential of amiloride with neuropharmacolgical benefits in some rodent models of epilepsy and behaviour Epilep and Behav 2004; 5(3): 523-530
16. Wolfe G. The evaluation of the analgesic action of pethidine hydrochloride. J Pharmacol Exp Ther 1944; 80: 300-307
17. Braham D, Trinder P. An improved colour reaction for the determination of blood glucose by oxidase system. Analyst 1972;97 142-144
18. Gonen B, Rubenstein AH, Tanega SP, Horwitz DL. Haemoglobin A1: an indicator of the metabolic control of diabetic patients. Lancet 1978; 2: 734-737
19. Zhang DL, Zhang YT, Yin JJ, Zhao BL. Oral administration of crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils. Journal of Neurochemistry 2004; 90: 211-219
20. Ellman GL. Tissue suphahydryl group. Archives of Biochemistry Biophysics 1957; 82: 72-77
21. Clairbone AL. Assay of catalase, In "Handbook of Methods of oxygen free radical research" Greenworld RA (Eds). CRC press, Boca Raton. 1985; pp.283-284
22. Marklund S, Marklund G. Involvement of superoxide anion radical in autooxidation by pyrogallol and a convenient assay of superoxide dismutase. Eur J Biochem 1974; 47: 469-474
23. Belur B, Kandaswamy N, Mukherjee KL. Laboratory techniques in histopathology. In "Medical laboratory technology- A procedure manual for routine diagnostic tests, Tata McGraw Hill Co. Ltd. Delhi-2. 1990; pp. 1124-1188
24. Lowry OH, Rosenburg NJ, Farr AL, Randale RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275
25. Sufyan GS, Ashutosh K, Shyam SS. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sciences 2006;79: 777-783
26. Al-Hader A, Aquel M, Hasan Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. International Journal of Pharmacology 1993; 31: 96-100. (Pubitemid 23177256)
27. Fararh KM, Atoji Y, Shimizu T, Shiina H, Nikami T, Takewaki H. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Research in Veterinary Science 2004; 77: 123-129 (Pubitemid 38950326)
28. Salma CR, Souhail B, Basma H, Christophe B, Claude D, Hamadi A. Nigella sativa L.: Chemical composition and physicochemical characteristics of lipid fraction. Food Chemistry 2007; 101:673-681
29. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1585
30. Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004; 53:1543-1548
31. Ash G, Dickens CM, Creed FH, Jayson MI, Tomenson B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology 1999; 38: 959-967 (Pubitemid 29505077)
32. Nicolas A, Jean-Pierre G, Joseph F, Alain E, Francois C. A new animal model of vincristineinduced nociceptive peripheral neuropathy. Neurotoxicology 2003; 24: 797-805. (Pubitemid 37486255)
33. Kenneth D, Cliffer JA, Siuciak SR, Carson HE, Radley JS, Park DR, Lewis Z, Trang N, Karen G, James R, Tonra NS, Jesse MC, Sue CB, Ronald ML, Peter SD. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Annals of Neurology 2004; 43(1): 146-155
34. Mahmood D. Comparative evaluation of amitriptyline and sertraline in diabetic neuropathy. Department Of Pharmacology. Faculty of Pharmacy, Jamia Hamdard (Hamdard University) New Delhi -110062, 2006 pp.48-50.
35. Cameron NE, Jack AM, Cotter MA. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Red Biol Med 2001; 31(1): 125-135 (Pubitemid 32568432)
36. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001;50(8):1927-1937 (Pubitemid 33641615)
37. Maritim AC, Sanders RA, Watkins JB. Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Neut Bio 2003;14(5): 288-294 (Pubitemid 36794267)
38. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997;46(2): 38-42.
39. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997; 46( Suppl2): S62-6.
40. Simmons Z, Feldman EL. Neuromuscular diseases. Current Opinion in Neurology 2002; 15(5):595-603.
41. Yanping Wang, JD, Schmelzer AS, Harmyabu I, Low PA. Ischemia reperfusion injury of perepheral nerve in experimental diabetic neuropathy. J Neural Sci 2004; 227:101-107 (Pubitemid 39491132)
42. Kanter, M. Effects of Nigella sativa and its major constituents, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 2008; 33(1): 87-96. (Pubitemid 350242795)